Report: Diplomat aims for $1 billion revenue mark in 2012
FLINT, Mich. — For the last several years, Diplomat Specialty Pharmacy has been widely recognized as one of the top privately owned companies in the country, but now it’s aiming even higher.
President and co-founder Phil Hagerman told the Flint, Mich., Journal that Diplomat is hoping to earn $1 billion in revenues next year. The company is expected to have more than $800 million in revenues this year.
Inc. magazine included Diplomat on its annual list of the fastest-growing private companies for three years in a row, ranking the company at 1,201-out-of-5,000 this year. In July, when Diplomat received Trade and Industry Development Magazine’s CiCi Award, Hagerman said the company plans to hire 1,000 people over the next five years and 4,000 people by 2028 in such jobs as nursing, pharmacy, information technology and call-center operations. Many of those jobs will be at its new headquarters, at Flint’s Great Lakes Technology Centre.
New initiative for GNP’s Mike Quick: Expand independent pharmacy base
VALLEY FORGE, Pa. — Good Neighbor Pharmacy, a network of more than 3,700 independently owned and operated community pharmacies, on Wednesday announced the creation of a new position, with Mike Quick named as national VP, GNP development.
Quick will be responsible for securing new business and retaining existing customers through the expansion of Good Neighbor Pharmacy throughout the United States and Canada by facilitating acquisitions, ownership transfers, expansions and startups of independent pharmacies and small- to medium-size chains, with the goals of preserving and growing business through expanding the Good Neighbor Pharmacy membership.
Quick was part of the team that created the Good Neighbor Pharmacy network for Bergen Brunswig, a legacy company of AmerisourceBergen. Quick also has established partnerships between Good Neighbor Pharmacy and several university pharmacy programs.
“Mike will help Good Neighbor Pharmacy carry on our mission of supporting entrepreneurial pharmacy ownership," GNP president Mike Cantrell said. "His relationships with our current members and his work with pharmacy schools will foster an atmosphere conducive to independent pharmacy ownership."
NCPA, APhA members to play critical role in government’s Million Hearts campaign
ALEXANDRIA, Va. — As part of the launch of the Department of Health and Human Services’ Million Hearts campaign on Tuesday, HHS identified several key association partners, including the National Community Pharmacist Association and the American Pharmacists Association.
“NCPA enthusiastically supports the Million Hearts Initiative and will encourage all 23,000 independent community pharmacies to become involved," NCPA president Bob Greenwood said. “Many community pharmacists currently offer disease state management programs supporting the Million Hearts goal. These include blood pressure and lipid monitoring, smoking cessation services, and NCPA’s new Simplify My Meds adherence program, which provides pharmacists with tools to coordinate a patient’s refills to occur on a single day and boost medication adherence."
“The Million Hearts Initiative presents an opportunity for pharmacists to reach out to their patients with a range of pharmacy-based cardiovascular maintenance services,” APhA EVP and CEO Thomas Menighan said. “The HHS, CDC and CMS have asked APhA pharmacists to be principal partners in this initiative, along with the [American Medical Association] and the [American Nurses Association], recognizing the important role we play in patient care. Pharmacists are ideally positioned to help manage blood pressure and cholesterol medication therapy and empower patients to take control of their cardiovascular health by adhering to their medication regimens.”
Million Hearts is a private-public joint initiative that aims to prevent 1 million heart attacks and strokes over the next five years. By empowering Americans to make healthy choices and improving care across independent pharmacies and Walgreens, a chain partner also identified Tuesday, Million Hearts strives to achieve the following specific goals by 2017:
Daily supplementation of 81 mg aspirin by 65% of people at high risk, up from a baseline of 47% today;
Blood pressure control by 65% of high-risk people from a baseline of 46%;
Effective treatment of high cholesterol (from 33% to 65%);
Reduce smoking prevalence (from 19% to 17%);
Reduce average daily sodium intake by 20% — Americans on average consumer 3.5 g of sodium per day; and
Realize a 50% reduction in artificial trans fat consumption, which today represents 1% of calories consumed per day.
“Through this public-private partnership, Million Hearts focuses on the areas that will save the most lives. It leverages and aligns current investments and is a great example of getting more health value from our existing health investments,” Centers for Disease Control and Prevention director Thomas Frieden said. “If we succeed in achieving our Million Hearts goals, 10 million more Americans with high blood pressure will have it under control, 20 million more Americans with high cholesterol will have it under control, and 4 million fewer Americans will smoke by 2017.”
CDC is announcing a $2 million Pharmacy Outreach Project to team up with pharmacists to provide additional advice and support to patients diagnosed with high blood pressure. In addition, CDC is announcing $4.2 million in funds to seven national networks of community-based organizations to support, disseminate and amplify the reach of the Community Transformation Grant program. Later this month, CDC will announce another $100 million in grants to communities across the country focused on reducing smoking, improving nutrition and promoting blood pressure control.